Viral Infection Study
Phase 4
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/06/034327
- Lead Sponsor
- Apollo Hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Confirmed diagnosis of COVID 19 infection(COVID RT-PCR positive or HRCT suggestive of CORADS 4/5/6)
Mild disease presenting within the first 7 days of illness
Exclusion Criteria
Children with moderate or severe COVID 19 infection at presentation.
Children with comorbidities on immunosuppressants or on steroids.
Parents or guardian not consenting to be part of the study.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect on disease progression in children affected with COVID 19Timepoint: 14 days
- Secondary Outcome Measures
Name Time Method Effect on symptom controlTimepoint: 14 days